Coronavirus (COVID-19) Update: Daily Roundup

N/A

Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic

Coronavirus (COVID-19) Update: Daily Roundup

FDA approves treatment for the control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors.

The FDA announces that it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately

Coronavirus (COVID-19) Update: Daily Roundup

FDA has stood up a new program to expedite the development of potentially safe and effective life-saving treatments for COVID-19.

Coronavirus (COVID-19) Update: Daily Roundup

: Coronavirus (COVID-19) Update: FDA expedites review of diagnostic tests to combat COVID-19

The President signed into law a $2 trillion emergency relief bill that will continue to aid the response efforts and ease the economic impact of COVID-19.

FDA takes further steps to help mitigate supply interruptions of food and medical products

Coronavirus (COVID-19) Update: Daily Roundup

FDA took action to help increase the supply of ventilators and respirators due to shortages during COVID-19

Coronavirus (COVID-19) Update: Daily Roundup

After receiving useful feedback as part of the Clinical Data Summary Pilot Program, FDA has decided to conclude the pilot. FDA continues to invest in our work with international partners.

Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: Daily Roundup

Coronavirus (COVID-19) Update: FDA takes action to increase U.S. supplies through instructions for PPE and device manufacturers